Turnstone Biologics Corp Alpha and Beta Analysis

TSBXDelisted Stock   0.36  0.00  0.00%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Turnstone Biologics Corp. It also helps investors analyze the systematic and unsystematic risks associated with investing in Turnstone Biologics over a specified time horizon. Remember, high Turnstone Biologics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Turnstone Biologics' market risk premium analysis include:
Beta
0.82
Alpha
0.14
Risk
0.0
Sharpe Ratio
0.0
Expected Return
0.0
Please note that although Turnstone Biologics alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Turnstone Biologics did 0.14  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Turnstone Biologics Corp stock's relative risk over its benchmark. Turnstone Biologics Corp has a beta of 0.82  . As returns on the market increase, Turnstone Biologics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Turnstone Biologics is expected to be smaller as well. .
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

Turnstone Biologics Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Turnstone Biologics market risk premium is the additional return an investor will receive from holding Turnstone Biologics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Turnstone Biologics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Turnstone Biologics' performance over market.
α0.14   β0.82

Turnstone Biologics Fundamentals Vs Peers

Comparing Turnstone Biologics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Turnstone Biologics' direct or indirect competition across all of the common fundamentals between Turnstone Biologics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Turnstone Biologics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Turnstone Biologics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Turnstone Biologics by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Turnstone Biologics to competition
FundamentalsTurnstone BiologicsPeer Average
Return On Equity-1.27-0.31
Return On Asset-0.58-0.14
Current Valuation(8.06 M)16.62 B
Shares Outstanding23.14 M571.82 M
Shares Owned By Insiders7.69 %10.09 %
Shares Owned By Institutions51.49 %39.21 %
Number Of Shares Shorted281.36 K4.71 M

Turnstone Biologics Opportunities

Turnstone Biologics Return and Market Media

The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Turnstone Biologics Agrees to Acquisition by XOMA Royalty TSBX Stock News
06/27/2025
2
HAREHOLDER ALERT Class Action Attorney Juan Monteverde Investigates the Merger of Turnstone Biologics Corp.
06/30/2025
3
How did TSBXs revenue and expenses trend in Q4 2024 - AInvest
07/03/2025
4
Is Turnstone Biologics Corp. a good long term investment - Free Stock Chart Pattern Guide - jammulinksnews.com
07/22/2025
5
New Product Launches Will They Boost Turnstone Biologics Corp. Stock in 2025 - metal.it
07/30/2025

About Turnstone Biologics Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Turnstone or other delisted stocks. Alpha measures the amount that position in Turnstone Biologics Corp has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.

Turnstone Biologics Upcoming Company Events

As portrayed in its financial statements, the presentation of Turnstone Biologics' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Turnstone Biologics' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Turnstone Biologics' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Turnstone Biologics. Please utilize our Beneish M Score to check the likelihood of Turnstone Biologics' management manipulating its earnings.
8th of February 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View
8th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Turnstone Biologics

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Consideration for investing in Turnstone Stock

If you are still planning to invest in Turnstone Biologics Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Turnstone Biologics' history and understand the potential risks before investing.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments